Protara Therapeutics Stock Technical Analysis
| TARA Stock | USD 3.04 0.10 3.40% |
As of the 28th of November, Protara Therapeutics holds the Coefficient Of Variation of 633.32, risk adjusted performance of 0.1292, and Semi Deviation of 2.78. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protara Therapeutics, as well as the relationship between them.
Protara Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Protara, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProtaraProtara |
Protara Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 31.4 | Strong Buy | 4 | Odds |
Most Protara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Protara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Protara Therapeutics, talking to its executives and customers, or listening to Protara conference calls.
Protara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Protara Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Protara Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Protara Therapeutics Trend Analysis
Use this graph to draw trend lines for Protara Therapeutics. You can use it to identify possible trend reversals for Protara Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Protara Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Protara Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Protara Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.02 , which means Protara Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 11.87, which is the sum of squared deviations for the predicted Protara Therapeutics price change compared to its average price change.About Protara Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Protara Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Protara Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Protara Therapeutics price pattern first instead of the macroeconomic environment surrounding Protara Therapeutics. By analyzing Protara Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Protara Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Protara Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2020 | 2021 | 2022 | 2023 (projected) | PB Ratio | 0.88 | 0.47 | 0.3 | 0.31 | Capex To Depreciation | 4.51 | 5.09 | 0.48 | 0.13 |
Protara Therapeutics November 28, 2024 Technical Indicators
Most technical analysis of Protara help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protara from various momentum indicators to cycle indicators. When you analyze Protara charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1292 | |||
| Market Risk Adjusted Performance | 3.44 | |||
| Mean Deviation | 3.37 | |||
| Semi Deviation | 2.78 | |||
| Downside Deviation | 3.25 | |||
| Coefficient Of Variation | 633.32 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.57 | |||
| Information Ratio | 0.1288 | |||
| Jensen Alpha | 0.6478 | |||
| Total Risk Alpha | 0.0216 | |||
| Sortino Ratio | 0.1706 | |||
| Treynor Ratio | 3.43 | |||
| Maximum Drawdown | 19.48 | |||
| Value At Risk | (4.98) | |||
| Potential Upside | 8.67 | |||
| Downside Variance | 10.58 | |||
| Semi Variance | 7.73 | |||
| Expected Short fall | (4.49) | |||
| Skewness | 0.8175 | |||
| Kurtosis | 0.6364 |
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |